A lipidomic screen of hyperglycemia-treated HRECs links 12/15-Lipoxygenase to microvascular dysfunction during diabetic retinopathy via NADPH oxidase

Alterations of Retinal Vasculature in Cystathionine–β-Synthase Heterozygous Mice

(2014) Amany Tawfik et al.   AMERICAN JOURNAL OF PATHOLOGY

Bone morphogenetic protein 2: A potential new player in the pathogenesis of diabetic retinopathy

(2014) Khaled A. Hussein et al.   EXPERIMENTAL EYE RESEARCH

Eicosanomic profiling reveals dominance of the epoxygenase pathway in human amniotic fluid at term in spontaneous labor

(2014) Krishna Rao Maddipati et al.   FASEB JOURNAL

Gingerol-derivatives: emerging new therapy against human drug-resistant MCF-7

(2014) Ahmed S. Ibrahim et al.   TUMOR BIOLOGY

15-Lipoxygenase Promotes Chronic Hypoxia–Induced Pulmonary Artery Inflammation via Positive Interaction With Nuclear Factor-κB

(2013) Jing Li et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Role of phospholipases A2 in diabetic retinopathy: In vitro and in vivo studies

(2013) Gabriella Lupo et al.   BIOCHEMICAL PHARMACOLOGY

Association Between Plasma Triglycerides and High-Density Lipoprotein Cholesterol and Microvascular Kidney Disease and Retinopathy in Type 2 Diabetes Mellitus

(2013) Frank M. Sacks et al.   CIRCULATION

Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature

(2013) K Ghasemi Falavarjani et al.   EYE

12/15-Lipoxygenase-Derived Lipid Metabolites Induce Retinal Endothelial Cell Barrier Dysfunction: Contribution of NADPH Oxidase

(2013) Amira Othman et al.   PLoS One

Intravitreal Corticosteroid Therapy

(2012) Dennis P. Han   ARCHIVES OF OPHTHALMOLOGY

Turning a blind eye to anti-VEGF toxicities

(2012) Susan E. Quaggin   JOURNAL OF CLINICAL INVESTIGATION

Anti-Angiogenesis Drugs in Diabetic Retinopathy

(2011) V. Swetha E. Jeganathan   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Retinal Microglial Activation and Inflammation Induced by Amadori-Glycated Albumin in a Rat Model of Diabetes

(2011) A. S. Ibrahim et al.   DIABETES

Increased Expression and Activity of 12-Lipoxygenase in Oxygen-Induced Ischemic Retinopathy and Proliferative Diabetic Retinopathy: Implications in Retinal Neovascularization

(2011) M. Al-Shabrawey et al.   DIABETES

Expanded 2-Year Follow-up of Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema

(2011) Michael J. Elman et al.   OPHTHALMOLOGY

Profile of Lipid and Protein Autacoids in Diabetic Vitreous Correlates With the Progression of Diabetic Retinopathy

(2010) M. L. Schwartzman et al.   DIABETES

Seeing the future of bioactive lipid drug targets

(2010) Jilly F Evans et al.   Nature Chemical Biology

Lycopene inhibits PDGF-BB-induced retinal pigment epithelial cell migration by suppression of PI3K/Akt and MAPK pathways

(2009) Chi-Ming Chan et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

The 15(S)-hydroxyeicosatetraenoic acid-induced angiogenesis requires Janus kinase 2-signal transducer and activator of transcription-5B-dependent expression of interleukin-8

(2009) S. Y. Cheranov et al.   BLOOD

5-Lipoxygenase, but Not 12/15-Lipoxygenase, Contributes to Degeneration of Retinal Capillaries in a Mouse Model of Diabetic Retinopathy

(2008) R. A. Gubitosi-Klug et al.   DIABETES

Endogenous VEGF Is Required for Visual Function: Evidence for a Survival Role on Müller Cells and Photoreceptors

(2008) Magali Saint-Geniez et al.   PLoS One

Soluble ICAM-1 and VCAM-1 as Markers of Endothelial Activation

(2008) V. Videm et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY